Table 3

Annual occurring and averted events in 2035

Per 100 000 people
EventsNo intervention (CI)20% reduction (CI)Difference (CI)50% reduction (CI)Difference (CI)
T2D cases1034.6 (1031.0–1038.2)1014.7 (1011.3–1018.2)19.9 (12.8–27.0)951.2 (947.9–954.4)83.5 (76.7–90.3)
T2D deaths576.6 (574.2–578.9)569.3 (567.0–571.6)7.2 (2.7–11.8)546.4 (544.2–548.6)30.2 (25.7–34.6)
CHD cases665.1 (661.9–668.2)655.6 (652.5–658.8)9.4 (3.1–15.8)626.1 (623.1–629.1)39.0 (32.8–45.2)
CHD deaths203.6 (202.2–205.0)201.9 (200.5–203.3)1.6 (−1.2–4.4)197.2 (195.9–198.6)6.3 (3.6–9.1)
HCC cases4.4 (4.32–4.41)4.0 (3.95–4.05)0.3 (0.24–0.39)3.1 (3.02–3.18)1.3 (1.24–1.38)
Liver deaths19.8 (19.65–20.02)18.5 (18.29–18.63)1.4 (1.02–1.73)14.1 (13.94–14.21)5.8 (5.44–6.08)
  • CHD, coronary heart disease; CI, 95% central coverage interval; HCC, hepatocellular carcinoma; NASH, non-alcoholic steatohepatitis; T2D, type 2 diabetes.

  • Numbers might not add up due to rounding.